Shaping the future of genomics at Landspitali University Hospital and the University of Iceland (Háskóli Íslands) ! 🧬 🌋 It was an exciting start with Oxford Nanopore Technologies and the PromethION P24, sequencing samples in the field of neurodevelopmental disorders , a true step forward in bridging cutting-edge technology with meaningful clinical research. ✨Heartfelt thanks to the amazing Landspítali team for the warm hospitality and for your dedication throughout the training. Your energy and collaboration are what make progress possible! 🙌

Spending great days at Næstved Sygehus supporting Bettina Pedersen and Jette with their colorectal cancer microbiome project using Oxford Nanopore Technologies. It’s inspiring to see how real-time sequencing is being integrated into clinical research to better understand the role of the microbiome in colorectal cancer. Huge thanks to Bettina and Jette for the warm welcome and meaningful collaboration!#NanoporeSequencing

Just had the pleasure of attending the DSMG Seminar, and it opened with an incredibly insightful talk by Prof. Martin Jakob Larsen setting the tone for an exciting event. Prof. Larsen presented on the significance of nanopore sequencing in uncovering the genetic basis of rare diseases and imprinting disorders — a technology that’s proving to be transformative in clinical genomics.His talk highlighted remarkable case resolutions, including: A complex chromosomal translocation involving the SMAD4 gene,leading to both juvenile polyposis syndrome and hereditary hemorrhagic telangiectasia.A unique case of a Silver-Russell-like phenotype, traced back to imprinting defects in the IGF2 gene.It’s exciting to see how Oxford Nanopore Technologies long-read sequencing is opening new doors in diagnosing and understanding disorders that were previously elusive with traditional methods.Looking forward to the rest of the seminar and the discussions ahead!

What an amazing opportunity to present the power and ease of Nanopore Sequencing at the Long Read Sequencing Uppsala Conference! We demonstrated live sequencing on stage, along with real-time data analysis, in front of an incredible audience full of energy and enthusiasm. Proud to be part of such an innovative and inspiring event!

We’re live at the Precision Medicine Networking Forum in Riga, Latvia! Curious about how Oxford Nanopore Technologies is shaping the future of personalized medicine? 🧬 Stop by our booth for a hands-on look at real-time sequencing and discover how we’re pushing the boundaries of precision healthcare. Don’t miss out—come chat with us and see the future of genomics in action! 🔬

Always a pleasure to return to the University of Bergen (UiB) , where I matured as a scientist during my PhD and postdoc years. This time, I had the opportunity to present the latest advances of Oxford Nanopore Technologies and share our success stories. Grateful for the warm welcome and the invitation. looking forward to more inspiring discussions!

🌟 It was an honor to engage with such a vibrant audience at the “What You Are Missing Matters” seminar in Riga, Latvia, hosted by Oxford Nanopore Technologies at the Latvian Biomedical Research & Study Centre. Your enthusiasm and curiosity made the event exceptional. We look forward to many more enlightening sessions and groundbreaking discoveries together.

🎉 Successful “What You Are Missing Matters” Oxford Nanopore Technologies Day at Tampere University! 🎉 Great engagement with our flow cell demonstration and insightful questions about nanopore technology. Thanks to everyone who participated and made this event a success!

🌟 Thrilled to have joined the bioinformatics team at the Oxford Nanopore Technologies London Calling event! Sharing this journey with inspiring speakers and groundbreaking news was incredible.

What a fantastic time at the ‘What You Are Missing Matters’ Oxford Nanopore Technologies Day at Vilnius University, Life Sciences Center! Let’s keep exploring Nanopore sequencing!

Remarkable progress is happening at Rigshospitalet’s Dept of Pathology! 🎉 We’re now performing rapid, in-depth CNS tumor classification post-surgery, transforming patient care. 🧠💥 A huge thank you to all who took part in our GridION Oxford Nanopore Technologies training. Let’s keep advancing and shaping the future of healthcare! 💪

The Society of Endocrinology has awarded ‘The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms’ by Andreas Venizelos et al. an SfE Journal Award for excellence in endocrine research and practice.

Excited to be at the BioNordika Denmark A/S NGS Nordic Meeting, discussing “What’s Missing Matters” by harnessing the power of long reads from Oxford Nanopore Technologies. Uncovering the hidden gems of genomics!

Returning to Bergen, Norway brings back amazing memories of 7 years as a scientist. Thrilled to be back in my FAS role for this exciting Avantor scientific seminar. Dive deep into the world of science! Our ongoing seminar features talks from Marine Biologists, Cancer Genomics experts and more, all powered by Oxford Nanopore Technologies!

It’s a full house at our Oxford Nanopore Day Event in Stockholm, Sweden. Great engagement and networking going on!

Molecular markers predicting response to dose dense chemotherapy with epirubicin and docetaxel in sequence for locally advanced breast cancer

Genomic profiling of NECs

Personalized therapy of breast cancer